This is a limited company view. Sign up for a Free Trial to see everything.

AngioChem develops new drugs that are capable of crossing the blood-brain barrier to treat brain diseases.

B2B
Biotechnology
Healthcare
Pharmaceuticals
Physical Storage
Storage

Overview

Location

Montreal

Founded

2003

Employees

14

Stage

Pre-Series A

Total funding

$10M

Last funding

10 years ago

Acquisitions

0

Growth score

-44

Mindshare score

-32

Scoring

Deals

$3.0M Seed

MMV Financial

Dec 1, 2007

$807.0K Venture

BDC Venture Capital

Jan 1, 2005

Employee Growth

Use AngioChem's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use AngioChem's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

Associate Director, Manufacturing
VP Development
Lead Clinical Research Associate
Chemistry manager
Clinical Research Scientist
Accounting
Research Associate
TSA-assistante de recherche

Similar Companies

Aminex Therapeutics

Aminex Therapeutics Inc. develops small molecule based cancer treatment solutions. Its product, Polyamine-Blocker Therapy (PaBT),
Series A|8 employees

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes